These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 21057748)

  • 21. Stevens-Johnson syndrome and toxic epidermal necrolysis: a 20-year single-center experience.
    Lalosevic J; Nikolic M; Gajic-Veljic M; Skiljevic D; Medenica L
    Int J Dermatol; 2015 Aug; 54(8):978-84. PubMed ID: 25385069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel.
    Halevy S; Ghislain PD; Mockenhaupt M; Fagot JP; Bouwes Bavinck JN; Sidoroff A; Naldi L; Dunant A; Viboud C; Roujeau JC;
    J Am Acad Dermatol; 2008 Jan; 58(1):25-32. PubMed ID: 17919772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine.
    Kirchhof MG; Miliszewski MA; Sikora S; Papp A; Dutz JP
    J Am Acad Dermatol; 2014 Nov; 71(5):941-7. PubMed ID: 25087214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporine in SJS/TEN management: a brief review.
    Shokeen D
    Cutis; 2016 Mar; 97(3):E17-8. PubMed ID: 27023091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pneumocystis jirovecii Pneumonia in a Patient with Interstitial Lung Disease].
    Özkoç S; Alpaydın AÖ; Delibaş SB; Ergüden C; Akkoçlu A
    Turkiye Parazitol Derg; 2015 Mar; 39(1):66-9. PubMed ID: 25917588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allopurinol-Induced Stevens-Johnson Syndrome.
    Gupta SS; Sabharwal N; Patti R; Kupfer Y
    Am J Med Sci; 2019 Apr; 357(4):348-351. PubMed ID: 30638600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Harr T; French LE
    Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe cutaneous adverse drug reactions: who should treat, where and how?: Facts and controversies.
    Wolf R; Davidovici B
    Clin Dermatol; 2010; 28(3):344-8. PubMed ID: 20541690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Diagnosis and Management.
    Frantz R; Huang S; Are A; Motaparthi K
    Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
    Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W
    Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-induced Stevens-Johnson syndrome in Indian population: A multicentric retrospective analysis.
    Hirapara HN; Patel TK; Barvaliya MJ; Tripathi C
    Niger J Clin Pract; 2017 Aug; 20(8):978-983. PubMed ID: 28891542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of prior corticosteroid use on the clinical course of Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control analysis of patients selected from the multinational EuroSCAR and RegiSCAR studies.
    Lee HY; Dunant A; Sekula P; Mockenhaupt M; Wolkenstein P; Valeyrie-Allanore L; Naldi L; Halevy S; Roujeau JC
    Br J Dermatol; 2012 Sep; 167(3):555-62. PubMed ID: 22639874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Stevens-Johnson syndrome and toxic epidermal necrolysis in a teaching hospital in Lomé, Togo: retrospective study of 89 cases].
    Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Tchangaï-Walla K; Pitché P
    Med Trop (Mars); 2010 Jun; 70(3):255-8. PubMed ID: 20734593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stevens-Johnson syndrome and toxic epidermal necrolysis overlap in a patient receiving cetuximab and radiotherapy for head and neck cancer.
    Urosevic-Maiwald M; Harr T; French LE; Dummer R
    Int J Dermatol; 2012 Jul; 51(7):864-7. PubMed ID: 22715836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Greater mechanistic understanding of the cutaneous pathogenesis of Stevens-Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review.
    Ogiji ED; Aboheimed N; Ross K; Voller C; Siner R; Jensen RL; Jolly CE; Carr DF
    Curr Opin Allergy Clin Immunol; 2024 Aug; 24(4):218-227. PubMed ID: 38753537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Fritsch PO; Sidoroff A
    Am J Clin Dermatol; 2000; 1(6):349-60. PubMed ID: 11702611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary co-infections by Pneumocystis jirovecii and Aspergillus fumigatus in non-HIV patients: A report of two cases and literature review.
    Markantonatou AM; Ioakimidou A; Arvaniti K; Manou E; Papadopoulos V; Kiriklidou P; Samaras K; Kioumi A; Vyzantiadis TA
    Mycoses; 2017 Oct; 60(10):626-633. PubMed ID: 28660636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study.
    Barvaliya M; Sanmukhani J; Patel T; Paliwal N; Shah H; Tripathi C
    J Postgrad Med; 2011; 57(2):115-9. PubMed ID: 21654132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of intravenous immunoglobulin in toxic epidermal necrolysis: a retrospective analysis of 64 patients managed in a specialized centre.
    Lee HY; Lim YL; Thirumoorthy T; Pang SM
    Br J Dermatol; 2013 Dec; 169(6):1304-9. PubMed ID: 24007192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.